EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · IEX Real-Time Price · USD
16.47
-1.10 (-6.26%)
At close: Apr 24, 2024, 4:00 PM
16.60
+0.13 (0.79%)
After-hours: Apr 24, 2024, 7:57 PM EDT
EyePoint Pharmaceuticals Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for EYPT stock have an average target of 35.63, with a low estimate of 22 and a high estimate of 55. The average target predicts an increase of 116.33% from the current stock price of 16.47.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 8, 2024.
Analyst Ratings
The average analyst rating for EYPT stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 2 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $33 | Strong Buy | Maintains | $33 | +100.36% | Mar 8, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $30 → $39 | Strong Buy | Maintains | $30 → $39 | +136.79% | Feb 16, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $35 | Buy | Initiates | $35 | +112.51% | Jan 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $35 → $33 | Strong Buy | Maintains | $35 → $33 | +100.36% | Jan 16, 2024 |
| Capital One | Capital One | Buy Initiates $44 | Buy | Initiates | $44 | +167.15% | Dec 11, 2023 |
Financial Forecast
Revenue This Year
38.34M
from 46.02M
Decreased by -16.68%
Revenue Next Year
11.66M
from 38.34M
Decreased by -69.59%
EPS This Year
-1.98
from -1.82
EPS Next Year
-2.58
from -1.98
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 57.8M | 23.9M | 7.0M | 224.6M | 531.5M |
| Avg | 38.3M | 11.7M | 2.9M | 147.0M | 307.3M |
| Low | n/a | n/a | n/a | 62.2M | 11.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 25.5% | -37.6% | -40.0% | 7,583.9% | 261.5% |
| Avg | -16.7% | -69.6% | -74.9% | 4,929.8% | 109.0% |
| Low | - | - | - | 2,029.0% | -92.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.48 | -2.06 | -2.09 | -1.28 | 1.77 |
| Avg | -1.98 | -2.58 | -2.75 | -1.80 | -0.07 |
| Low | -2.69 | -3.06 | -3.32 | -2.25 | -1.79 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.